CEVA SOINS
ActiveSummary
CEVA SOINS has been active since 2010 and the Belgian State Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €95,027 and a net result of €20,057. Equity is growing by ~16.7% per year across the filed fiscal years. The computed 12-month bankruptcy probability is 0.2% (very low).
History
Acts, filings and financial milestones
Next filing, fiscal year 2026, expected by
2026
24-09
NBB filing
Annual accounts filed
fiscal year 2025 · micro schema · 55 days late
2025
31-12
Financial
Highest result since 2018net €20,057 ▲54.8%
Operating result €31,876, net result €20,057, both a record.
29-12
NBB filing
Annual accounts filed
fiscal year 2024 · micro schema · 151 days late
2024
31-08
NBB filing
Annual accounts filed
fiscal year 2023 · micro schema · 31 days late
2023
31-12
Financial
Back to profitnet €17,909
Net result €17,909 after one loss-making year.
31-10
NBB filing
Annual accounts filed
fiscal year 2022 · micro schema · 92 days late
22-02
NBB filing
Annual accounts filed
fiscal year 2021 · micro schema · 206 days late
22-02
NBB filing
Annual accounts filed
fiscal year 2020 · micro schema · 571 days late
2020
31-10
NBB filing
Annual accounts filed
fiscal year 2019 · micro schema · 92 days late
2019
31-12
Financial
Back to profitnet €3,280
Net result €3,280 after one loss-making year.
27-11
NBB filing
Annual accounts filed
fiscal year 2018 · micro schema · 119 days late
2018
29-09
NBB filing
Annual accounts filed
fiscal year 2017 · micro schema · 60 days late
2017
30-09
NBB filing
Annual accounts filed
fiscal year 2016 · micro schema · 61 days late
Financial milestoneNBB filingFinancial milestones sit on the fiscal year-end date, not the filing date.
0 of 1 act read
About the unread acts
We know of 1 Belgian State Gazette act for this company. It has not been read yet: what they contain is neither established nor disproved here.
Have them read with priority
Sign in to place this company at the front of the reading queue.